Clinical significance of human papillomavirus genotyping.
- Author:
Youn Jin CHOI
1
;
Jong Sup PARK
Author Information
- Publication Type:Review
- Keywords: DNA Tests; Genotype; Human Papillomavirus; Uterine Cervical Neoplasms; Vaccine
- MeSH: DNA, Viral/*analysis; Early Detection of Cancer/*methods; Female; *Genome, Viral; Genotype; Humans; Papillomaviridae/classification/*genetics; Papillomavirus Infections/complications/drug therapy/*virology; Papillomavirus Vaccines/therapeutic use; Uterine Cervical Neoplasms/diagnosis/drug therapy/*virology
- From:Journal of Gynecologic Oncology 2016;27(2):e21-
- CountryRepublic of Korea
- Language:English
- Abstract: Cervical cancer is the fourth most common cancer in women worldwide, and the human papillomavirus (HPV) is the main causative agent for its development. HPV is a heterogeneous virus, and a persistent infection with a high-risk HPV contributes to the development of cancer. In recent decades, great advances have been made in understanding the molecular biology of HPV, and HPV\'s significance in cervical cancer prevention and management has received increased attention. In this review, we discuss the role of HPV genotyping in cervical cancer by addressing: clinically important issues in HPV virology; the current application of HPV genotyping in clinical medicine; and potential future uses for HPV genotyping.
